Neurocrine Biosciences is an established biotechnology firm focused on neuroscience, movement disorders, neuroendocrinology, and psychiatric conditions. The company has developed a commercial base while continuing to invest in neurological and psychiatric pipelines.
Read More
National Resilience is an established healthcare institution whose principal relevance to this ranking lies in advanced biologics, nucleic acid and cell-therapy manufacturing. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in biomanufacturing & CDMO Providers.
Read More
NAMSA is an established healthcare institution whose principal relevance to this ranking lies in medical-device clinical research, regulatory and testing services. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in contract Research Organizations. NAMSA is headquartered in Northwood, Ohio, and has been an ARCHIMED company since 2020.
Read More
Moderna is one of the most important mRNA platform companies and a leading developer of next-generation vaccines and immunotherapies. The company’s COVID-19 vaccine validated its mRNA platform at global scale, while its future depends on expanding the platform into respiratory vaccines, personalized cancer vaccines, infectious disease, and broader therapeutic applications.
Read More
MilliporeSigma, the U.S. and Canada life science business of Merck KGaA, Darmstadt, Germany, is a major life science tools and services provider with CDMO capabilities relevant to biologics, viral vectors, process development, and advanced therapeutic manufacturing support.
Read More
Merck & Co. remains one of the most important pharmaceutical companies globally, anchored by its oncology leadership, vaccine portfolio, infectious disease expertise, and growing cardiometabolic and specialty medicine activity. Its position has been strongly shaped by Keytruda, one of the world’s most commercially significant oncology medicines.
Read More
Medpace is one of the strongest full-service CROs serving biotechnology and pharmaceutical sponsors, with particular strength among small and mid-sized biotech companies. The company is known for its medically led operating model, therapeutic specialization, integrated laboratory and core lab services, and disciplined execution.
Read More
Madrigal Pharmaceuticals is an established healthcare institution whose principal relevance to this ranking lies in metabolic liver-disease therapeutics. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in biotechnology Firms.
Read More
Lundbeck is one of the most focused specialty pharmaceutical companies in brain disease, with long-standing activity in psychiatry, neurology, depression, schizophrenia, migraine, Parkinson’s disease, and other central nervous system conditions.
Read More
Lonza is one of the world’s leading CDMO providers and a benchmark institution in biomanufacturing. The company supports pharmaceutical and biotechnology sponsors across biologics, small molecules, cell and gene therapy, drug product services, microbial manufacturing, mammalian cell culture, and advanced therapeutic manufacturing.
Read More
Legend Biotech is an established healthcare institution whose principal relevance to this ranking lies in commercial and pipeline CAR-T cell therapies. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in cell & Gene Therapy Developers.
Read More
Kyverna Therapeutics is a specialist cell therapy developer focused on autoimmune disease. Its platform applies CAR-T technology to B-cell mediated autoimmune conditions, reflecting one of the most important expansion areas for cellular immunotherapy.
Read More
Krystal Biotech is an increasingly important rare disease developer focused on genetic skin diseases and gene therapy. Its approved product Vyjuvek treats dystrophic epidermolysis bullosa, a severe genetic skin disorder, and has given the company a commercial rare disease platform.
Read More
Kiniksa Pharmaceuticals is a specialist rare disease company focused on inflammatory and cardiovascular-related orphan conditions. Its flagship product, Arcalyst, is approved for recurrent pericarditis and cryopyrin-associated periodic syndromes, giving the company a focused commercial rare disease platform.
Read More
KCR is an established healthcare institution whose principal relevance to this ranking lies in international clinical development and functional service provision. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in contract Research Organizations.
Read More
KBI Biopharma is a biologics CDMO providing process development, analytical development, formulation, microbial manufacturing, mammalian cell culture, and clinical manufacturing services. The company serves biotechnology and pharmaceutical sponsors developing proteins, antibodies, and other biologics.
Read More
KalVista Pharmaceuticals develops and commercializes oral therapies for hereditary angioedema. Chiesi completed its acquisition on 11 June 2026, making KalVista a wholly owned subsidiary; its common stock ceased trading on Nasdaq. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in rare Disease & Orphan Drug Developers.
Read More
Jazz Pharmaceuticals is a specialty pharmaceutical company focused on neuroscience, sleep medicine, oncology, and rare disease. The company’s commercial identity has been shaped by specialist-managed neurological and sleep disorders, as well as selected oncology products.
Read More
Ironwood Pharmaceuticals is an established healthcare institution whose principal relevance to this ranking lies in gastrointestinal specialty medicines. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in specialty Pharma Companies.
Read More
IQVIA is one of the most important Contract Research Organizations globally, combining large-scale clinical development services with healthcare data, analytics, real-world evidence, consulting, and technology platforms. Its position is distinctive because it operates not only as a CRO, but also as a healthcare information and analytics company serving pharmaceutical, biotechnology, payer, provider, and government clients.
Read More